These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15543299)

  • 1. Biosynthetic studies on the azinomycins: the pathway to the naphthoate fragment.
    Corre C; Landreau CA; Shipman M; Lowden PA
    Chem Commun (Camb); 2004 Nov; (22):2600-1. PubMed ID: 15543299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of 3-methoxy-5-methyl naphthoic acid and its incorporation into the antitumor antibiotic azinomycin B.
    Ding W; Deng W; Tang M; Zhang Q; Tang G; Bi Y; Liu W
    Mol Biosyst; 2010 Jun; 6(6):1071-81. PubMed ID: 20485749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the azinomycin B biosynthetic gene cluster revealing a different iterative type I polyketide synthase for naphthoate biosynthesis.
    Zhao Q; He Q; Ding W; Tang M; Kang Q; Yu Y; Deng W; Zhang Q; Fang J; Tang G; Liu W
    Chem Biol; 2008 Jul; 15(7):693-705. PubMed ID: 18635006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azinomycins A and B, new antitumor antibiotics. I. Producing organism, fermentation, isolation, and characterization.
    Nagaoka K; Matsumoto M; Oono J; Yokoi K; Ishizeki S; Nakashima T
    J Antibiot (Tokyo); 1986 Nov; 39(11):1527-32. PubMed ID: 3793621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of the molecular origin of the azinomycin epoxide: timing of the biosynthesis revealed.
    Sharma V; Kelly GT; Watanabe CM
    Org Lett; 2008 Nov; 10(21):4815-8. PubMed ID: 18841989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic manipulation of antibiotic-producing Streptomyces.
    Baltz RH
    Trends Microbiol; 1998 Feb; 6(2):76-83. PubMed ID: 9507643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro biosynthesis of the antitumor agent azinomycin B.
    Liu C; Kelly GT; Watanabe CM
    Org Lett; 2006 Mar; 8(6):1065-8. PubMed ID: 16524269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoacetone as the penultimate precursor to the antitumor agent azinomycin A.
    Sharma V; Kelly GT; Foulke-Abel J; Watanabe CM
    Org Lett; 2009 Sep; 11(17):4006-9. PubMed ID: 19663419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the Role of N-Acetyl-glutamyl 5-Phosphate, an Acyl Phosphate, in the Construction of the Azabicycle Moiety of the Azinomycins.
    Nepal KK; Lee RP; Rezenom YH; Watanabe CM
    Biochemistry; 2015 Jul; 54(29):4415-8. PubMed ID: 26161634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of AziR, a resistance protein of the DNA cross-linking agent azinomycin B.
    Foulke-Abel J; Kelly GT; Zhang H; Watanabe CM
    Mol Biosyst; 2011 Sep; 7(9):2563-70. PubMed ID: 21776524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first biosynthetic studies of the azinomycins: acetate incorporation into azinomycin B.
    Corre C; Lowden PA
    Chem Commun (Camb); 2004 Apr; (8):990-1. PubMed ID: 15069509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive products from Streptomyces.
    Bĕhal V
    Adv Appl Microbiol; 2000; 47():113-56. PubMed ID: 12876796
    [No Abstract]   [Full Text] [Related]  

  • 13. Essential role of an unknown gene aziU3 in the production of antitumor antibiotic azinomycin B verified by utilizing optimized genetic manipulation systems for Streptomyces sahachiroi.
    Wang S; Zhao R; Liu K; Zhu M; Li A; He J
    FEMS Microbiol Lett; 2012 Dec; 337(2):147-54. PubMed ID: 23039858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
    Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
    J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of a DNA-crosslinking azinomycin analogue.
    Casely-Hayford MA; Pors K; James CH; Patterson LH; Hartley JA; Searcey M
    Org Biomol Chem; 2005 Oct; 3(19):3585-9. PubMed ID: 16172698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of action of azinomycin B: definition of regioselectivity and sequence selectivity of DNA cross-link formation and clarification of the role of the naphthoate.
    Coleman RS; Perez RJ; Burk CH; Navarro A
    J Am Chem Soc; 2002 Nov; 124(44):13008-17. PubMed ID: 12405827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-mycaminose biosynthetic pathway revised and conversion of desosamine pathway to mycaminose pathway with one gene.
    Melançon CE; Yu WL; Liu HW
    J Am Chem Soc; 2005 Sep; 127(35):12240-1. PubMed ID: 16131199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved method for culturing Streptomyces sahachiroi: biosynthetic origin of the enol fragment of azinomycin B.
    Kelly GT; Sharma V; Watanabe CM
    Bioorg Chem; 2008 Feb; 36(1):4-15. PubMed ID: 17904193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of DNA cross-linking analogues based on the azinomycin scaffold.
    Alcaro S; Ortuso F; Coleman RS
    J Chem Inf Model; 2005; 45(3):602-9. PubMed ID: 15921450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineating noncovalent interactions between the azinomycins and double-stranded DNA: importance of the naphthalene substitution pattern on interstrand cross-linking efficiency.
    Landreau CA; LePla RC; Shipman M; Slawin AM; Hartley JA
    Org Lett; 2004 Sep; 6(20):3505-7. PubMed ID: 15387534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.